Incannex Healthcare stock tumbles after filing $100M offering
On Thursday, Stifel analysts reiterated a Buy rating on Salesforce.com (NYSE:CRM) with a consistent price target of $375.00. Currently trading at $276.03, with a market capitalization of $264.8 billion, InvestingPro analysis indicates the stock is currently undervalued. Following the company’s recent fiscal year commencement, Salesforce stock experienced a slight increase of approximately 1%. The analysts highlighted Salesforce’s strong positioning in the realm of agentic artificial intelligence, leveraging tools like Agentforce, Data Cloud, MuleSoft, Tableau, and the upcoming integration of Informatica.
The company’s management conveyed a highly optimistic outlook regarding Salesforce’s market position and the momentum they are observing. With impressive gross profit margins of 77.19% and revenue growth of 8.72%, Salesforce’s strategy appears to be gaining traction. The firm is planning to expand its go-to-market (GTM) capacity and realign GTM compensation structures, aiming to accelerate growth. This strategy is expected to be implemented while still prioritizing margin expansion. According to InvestingPro, the company maintains a GOOD financial health score, suggesting strong fundamentals to support its growth initiatives.
Stifel’s analysis suggests that while it is still the early stages for the monetization of Agentforce, there is optimism surrounding the company’s capability to secure multi-product deals that incorporate these new features. The endorsement from Stifel comes as Salesforce continues to assert its presence in the AI space and seeks to enhance its product offerings and market strategy. For a deeper understanding of Salesforce’s valuation and growth potential, access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Salesforce has reported strong financial results for the first quarter of fiscal year 2026, with revenue reaching $9.83 billion, an 8% year-over-year increase, and earnings per share (EPS) of $2.58, surpassing analyst expectations. The company’s subscription and support revenue grew by 9% in constant currency, reflecting its solid market position. Salesforce also raised its fiscal year 2026 revenue guidance to $41.3 billion, indicating confidence in its strategic initiatives and market position. Additionally, Salesforce announced an $8 billion acquisition of Informatica to enhance its data capabilities, which is expected to close in early fiscal 2027, subject to regulatory approval.
Analyst firms have responded positively to Salesforce’s recent performance. Morgan Stanley (NYSE:MS) raised its price target for Salesforce shares to $404, maintaining an Overweight rating, citing the company’s resilience and potential for continued success. JPMorgan also reiterated its Overweight rating with a $380 price target, highlighting Salesforce’s transformation into a profitable and cash-generative business. Goldman Sachs increased its price target to $385, maintaining a Buy rating, and emphasized the company’s strategic expansion in the Data and Artificial Intelligence (AI) market. JMP Securities reaffirmed its Market Outperform rating with a $430 price target, acknowledging Salesforce’s ability to exceed expectations amidst economic uncertainties.
Salesforce’s strong performance was driven by growth in its Data Cloud and AI segments, which have surpassed $1 billion in scale. The company reported that its Data Cloud and AI annual recurring revenue (ARR) exceeded $1 billion in the first quarter, with Agentforce ARR contributing approximately $100 million. Despite a slight operating margin miss in Q1, Salesforce’s free cash flow of $6.5 billion, representing a 64.1% margin, impressively exceeded consensus by $409 million. These developments underscore Salesforce’s strategic focus on expanding its AI and data capabilities, positioning the company for continued growth in the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.